The North America Parenteral Nutrition Market is expected to witness market growth of 7.3% CAGR during the forecast period (2021-2027).
The administration of parenteral drugs offers the advantages of rapid action and lower dose delivery that are helpful in the prevention of different negative effects due to dietary imbalances, hence boosting the development of parenteral nutritional products. In addition, various kinds of diseases like head & neck cancer, esophageal cancer, Crohn's, ulcerative colitis, gastric cancer, and laryngeal cancer can have an impact on oral food consumption among the patients. Due to their increasing occurrence, the parenteral nutrition market is expected to be propelled in the upcoming years. Though, some of the factors such as the huge risk of infection at the time of administration and the surge in the inclination of patients towards enteral nutrition pose barriers to the growth of the parenteral nutrition market.
The region is home to some of the leading market players, hence creating new growth avenues for the North American parenteral nutrition market. These players are also investing a high amount in the investment to develop better techniques. In addition, factors such as the rapid increment in the geriatric population and the increase in premature births around the world are estimated to boost the demand for parenteral nutrition products in the regional market.
Moreover, the surge in the number of metabolic disorders along with chronic diseases such as diabetes is one of the main factors fueling the growth of the parenteral nutrition market. The majority of individuals in the region are living an unhealthy lifestyle that could augment the demand for parenteral nutrition in the regional market.
The US market dominated the North America Trace Elements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $347.2 million by 2027. The Canada market is showcasing a CAGR of 12% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 11.1% during (2021 - 2027).
Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.
Scope of the Study
Market Segments Covered in the Report:
By Nutrient Type
- Single Dose Amino Acid Solution
- Parenteral Lipid Emulsion
- Carbohydrates
- Trace Elements,
- Vitamins & Minerals
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B.Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Methodology
LOADING...
